Laura Wallenstein Named Philanthropy Officer for the Lymphoma Research Foundation

Latest News

Laura Wallenstein Named Philanthropy Officer for the Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) recently named Laura Wallenstein as Chief Philanthropy Officer. As a member of the LRF senior leadership team, Wallenstein is responsible for the development and implementation of national strategic plans for all fundraising activities, including distinguished events, individual and planned giving, and peer-to-peer fundraising.

Prior to joining LRF, Wallenstein served as Senior Philanthropic Advisor at St. Jude Children’s Research Hospital where she successfully worked to identify and secure support for a $1 billion capital campaign and managed a portfolio of 150+ major, planned, and principal gifts donors and prospects. Wallenstein also held various development positions with increasing levels of responsibility at St. Jude Children’s Research Hospital, Vanderbilt University and Best Buddies International.

“Laura brings a unique combination of skills and experience to this role, which includes recognized success developing significant fundraising programs, as well as the intellect, leadership and ingenuity required to expand LRF’s mission and development programs,” said Meghan Gutierrez, LRF Chief Executive Officer. “Her deep and abiding commitment to philanthropy will inform her work and have an incredible impact on our ability to fund the most promising lymphoma research.”

“As the Lymphoma Research Foundation pursues its mission as the nation’s premier resource for lymphoma research and patient programs, the addition of Laura in this critical role represents an exciting new chapter in our organization’s evolution,” said Steven Eichberg, Chair of the LRF Board of Directors.

Our Mission and Impact

It was 1995 when the founders of the Lymphoma Research Foundation (LRF) realized its dual mission: to eradicate lymphoma – by funding innovative research – and serve those touched by this disease – by sharing research and treatment insights directly with the lymphoma community through national education programs and resources.